H Pharmaceutical Company Financial Competitiveness Research And Improvement Strategy

Over the years,with the improvement of people’s standard of living and the increasing emphasis on health,China’s pharmaceutical industry has experienced rapid development.But at the same time,along with our country carries on strong supervision to the pharmaceutical industry,the high demand,and the foreign pharmaceutical giant’s impact,has brought the huge challenge to our country’s pharmaceutical industry development.How to improve the competitiveness and maintain steady development in the fierce market is a common problem for pharmaceutical enterprises in China.Financial competitiveness is not only an important quantitative manifestation of enterprise competitiveness,but also a reflection of the comprehensive ability of enterprises.This paper combs the literature on the definition and evaluation of financial competitiveness,takes H Pharmaceutical Company,a well-known enterprise in the pharmaceutical industry,as the research object,and analyzes the basic financial situation of H Pharmaceutical Company from the aspects of profit income,balance sheet and cash flow by analyzing the characteristics of the pharmaceutical industry and the market operating environment faced by H Pharmaceutical Company.At the same time,in order to evaluate the financial competitiveness of H Pharmaceuticals more scientifically,the paper selected 140 listed pharmaceutical companies from2016-2020 as a sample,constructed a financial competitiveness evaluation index system consisting of four indicators: profitability,solvency,operating ability and development ability,adopted factor analysis and factor scoring formula,combined with the financial situation of H Pharmaceutical Company,to study the factors restricting the financial competitiveness of H Pharmaceutical Company,and put forward suggestions and countermeasures to help the development of H Pharmaceutical Company.The analysis found that H Pharmaceutical Company has weak revenue growth,low inventory turnover,single funding method,low turnover of accounts receivable,and other factors that restrict the development of financial competitiveness.In addition,based on the results of the analysis,H Pharmaceuticals has proposed innovative business products,cost control,accurate forecasting of supply and demand,abundant financing methods,and strengthening accounts receivable management.